Boehringer Ingelheim & Axine Water Ribbon-Cutting For A New Pharma Wastewater Treatment System
Axine Water Technologies and Boehringer Ingelheim have collaborated to implement a wastewater treatment system at Boehringer Ingelheim’s pharmaceutical plant in Barceloneta, Puerto Rico. Axine’s new system will treat and destroy active pharmaceutical ingredients (APIs) in rinse water to help Boehringer Ingelheim achieve the highest Predicted No-Effect Concentration (PNEC ) standards before discharge! Axine treats Wastewater for pharma manufacturers to help achieve their sustainability goals at low cost and low risk. Under multi-year service agreements, we deliver turnkey wastewater treatment solutions with guaranteed performance.
Boehringer Ingelheim shares a short testimonial of their experience collaborating with Axine to implement a new wastewater treatment system at Boehringer Ingelheim’s pharmaceutical plant in Barceloneta, Puerto Rico. Axine’s new on-site treatment system will help Boehringer achieve these goals by treating and destroying active pharmaceutical ingredients (API) in the clean-in-place (CIP) rinse water to achieve Predicted-No-Effect-Concentration (PNEC) before discharge.
Treating Active Pharmaceutical Ingredients (APIs) in Pharma Manufacturing Wastewater by Axine
This video from Axine Water (www.axinewater.com) profiles Axine’s latest on-site wastewater treatment system treating Active Pharmaceutical Ingredients (APIs) in rinse water from a new production line at a formulation plant in Puerto Rico. Our solution enables the plant to achieve a Predicted No-Effect Concentration (PNEC) standard for the APIs in the receiving water by combining Ultrafiltration (UF) and Reverse Osmosis (RO), with our proprietary electro-oxidation technology to provide guaranteed API destruction.